Eledon Pharmaceuticals, Inc.’s Post

GTG Signs Precision Medicine Pilot with Australia's Largest Private Hospital Network Genetic Technologies, Inc. (ASX: GTG; NASDAQ: GENE) – a global leader in genomics-based tests in health, wellness and serious disease is pleased to announce a partnership with the Gold Coast Private Hospital (GCPH), a member of Healthscope, to establish a Precision Medicine Clinic at the hospital. Highlights Positive outcomes could enable the rollout of additional Precision Medicine Clinics throughout the Healthscope network. Gold Coast Private Hospital by Healthscope is a 336 bed, 22 theatre hospital and home to leading doctors and surgeons from around the world. Healthscope is Australia's only national private hospital operation and healthcare provider with a network of 42 hospitals that service every state and territory with 19,000 employees. Read the full article: https://lnkd.in/ecT7trDQ Learn more about Genetic Technologies and view disclosures: https://ow.ly/ZTkQ50PQeyL #GENE #genetics #predictive #partnership

Immersing myself in the advancements of gene editing at the first-ever CRISPR Medicine Conference here at Copenhagen from 22nd to 25th April🧬 Excited to gain deeper insights into the technology, challenges, and regulations shaping this field, as well as the incredible potential it holds for revolutionizing patient care. #CRISPR #GeneEditing #CRISPRMedicine #CRISPRMED24

🔊 Lentiviral vectors for gene and gene-modified cell 🎤 Natalia Elizalde: “Lentiviral vectors can be used for a few applications. This is why #vivebiotech works among companies all around the world.” 🎤 Joost van den Berg: “Our 7-day workflow allow the treatment to be administered to patients with minimal wait time.” 🎤 Pierre Charneau: “The success of lentiviral vectors rely on the ability to efficiently traduce immature dendritic cells, both in vitro and in vivo.” 🎤 Pablo Menéndez: “These lentiviral vectors have been extensively used in the clinic and are well stablished for the regulatory agencies.” #BIOSPAIN2023 #AseBio

NEW HORIZONS 🌱 The potential of gene and cellular therapy to revolutionize healthcare is evident. However, realizing this potential requires innovative thinking, dedication, and significant investments. 🙋♀️ 🙋♂️ We believe collaboration and organization are paramount to keep moving forward, involving stakeholders across sectors and borders. 🤝 With new collaborations on the horizon, we aim to advance a Danish ecosystem for ATMP development and clinical translation, while simultaneously strengthening Nordic and international efforts. 🚀 Will you be part of the journey with us? (Picture: Rooftop view from the Forum building at Aarhus Universitetshospital) #geneandcellulartherapy #ATMP #transforminghealthcare #cgct #auh

Is this the next generation senolytic? Using genetically programmed CAR T cells to target uPAR-positive senescent cells, researchers were able to improve exercise capacity and metabolic dysfunction in aged mice. Most importantly, this only required a single treatment and the effects lasted for over a year, which raises the possibility of a "one-and-done" senolytic treatment. Prophylactic and long-lasting efficacy of senolytic CAR T cells against age-related metabolic dysfunction https://lnkd.in/exB3vuFt

High throughput workflows are critical to maximize output of bioluminescence imaging (BLI) studies, but they are traditionally difficult to achieve, especially in terms of data analysis and reporting TATs. By employing staggered scanning workflows and advanced, automated analytics, Invicro turns around large, complex datasets faster than the accepted norms, as fast decision making is key for drug development and gaining “real time” answers. In this webinar, Dr. @Patrick McConville reviews Invicro’s workflow capabilities through the lens of gene delivery and oncolytic virus examples. Discover: https://hubs.ly/Q02nZPY60 #bioluminescenceimaging #imagingCRO #preclinicalimaging

Dr. Stuart Orkin envisions a future where gene editing and pharmaceuticals make life-saving treatments accessible to all. Discover his goals and the potential impact on global health. 🌍💊   Celebrating the vision and future impact of Dr. Orkin's work on global health! Harvard Medical School #theshawprize #ShawPrize #ShawPrize2024 #GeneTherapy #GlobalHealth #LifeScienceandmedicine #MedicalResearch

Frontier and exponential genomic tech: Keeping humans in the loop - CRISPR, one of the most promising scientific advances of our time. Can this create assymetric risks? #biotech #crispr #privacy #biotechinnovation #ai #ml #syntheticbiology #biology #biometrics #privacyengineering #privacyenhancingtechnologies #epigenome #epigenetics #genomics

25 years in business and still leading in genetically engineered mouse models for biomedical research! #LegacyOfExcellence #25YearsStrong #ResearchLeadership #GeneticPioneers #DecadesOfDiscovery #ScientificMastery #geneediting #mousemodels #genetargeting

🌱 Our platform is at the forefront of enhancing AAV vector yields, achieving up to a 100-fold decrease in the cost of upstream processes. This efficiency leap is made possible by utilizing non-GMP controlled environment agriculture (CEA) facilities instead of traditional cGMP facilities, significantly reducing production costs. ❓Why does this matter? ⚕️The shift towards more cost-effective and efficient production methods is crucial for the future of gene therapy manufacturing. Lowering the barriers to high-quality production enables broader access to vital treatments for those in need. #AAV #GeneTherapy #Upstream #Manufacturing #GeneManufacturing #PlantScience #ViralVector #CostEffective #CEA